[1]于娟,张立平,孙宁,等.外泌体与自身免疫病的研究进展[J].医学研究生学报,2018,31(9):972-976.
[2]张莹,温利辉,王美美,等. 抗心磷脂抗体阳性的系统性红斑狼疮临床特点和预后分析[J].医学研究生学报,2019,32(9):958-962.
[3]刘颖,梅焕平,吴云娟,等. 抗内皮细胞抗体在多发性肌炎/皮肌炎合并间质性肺疾病中的应用[J].东南国防医药,2016,18(3):278-280,286.
[4]Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing[J]. Arthritis Rheum,2002,47(4):434-444.
[5]Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies[J]. Ann Rheum Dis,2014,73(1):17-23.
[6]胡朝军,周仁芳,张蜀澜,等.抗核抗体HEp-2细胞间接免疫荧光模型及其结果报告方式国际共识解读[J].中华检验医学杂志,2016,39(11):804-810.
[7]Meroni PL, Schur PH. ANA screening: an old test with new recomm- endations[J]. Ann Rheum Dis,2010,69(8):1420-1422.
[8]Chan EK, Damoiseaux J, Carballo OG, et al.Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015 [J]. Front Immunol,2015,6:412.doi: 10.3389/fimmu.2015.00412.
[9]孟新艳, 武丽君. 抗核抗体致密颗粒型与抗环瓜氨酸肽抗体及RF Ig-AGM的相关性[J]. 世界最新医学信息文摘(电子版), 2017,17(83): 145-146.
[10]张道强, 隋秀梅, 张春江, 等. 抗核抗体致密斑点型与抗环瓜氨酸肽抗体的相关性及临床意义研究[J]. 中华微生物学和免疫学杂志, 2011, 31(6): 516.
[11]周仁芳,曾爱平,陈瑛,等.致密细斑点型抗核抗体在自身免疫性疾病中的临床意义[J].中华检验医学杂志,2015,38(3):173-177.
[12]Gundín S, Irure-Ventura J, Asensio E,et al. Measurement of anti-DFS70 antibodies in patients with ANA-associated autoimmune rheumatic diseases suspicion is cost-effective[J]. Autoimmun Highlights,2016,7(1):10.
[13]Carter JB, Carter S, Saschenbrecker S,et al. Recognition and Rele-vance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital[J]. Front Med (Lausanne),2018,5:88.
[14]Mahler M, Hanly JG, Fritzler MJ.Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases[J].Autoimmun Rev,2011,11(9):642-645.
[15]Mahler M,Parker T,Peebles CL,et al.Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases[J]. J Rheumatol,2012,39(11): 2104-2110.